EMAIL THIS PAGE TO A FRIEND

BMC immunology

Morphological change of CD4(+) T cell during contact with DC modulates T-cell activation by accumulation of F-actin in the immunology synapse.


PMID 26306899

Abstract

The changes in T-cell morphology during immunological synapse (IS) formation are essential for T-cell activation. Previous researches have shown that T cell changed from spherical to elongated and/or flattened during in contact with B cell. As most powerful antigen presenting cell, dendritic cell (DC) has a strong ability to activate T cells. However, the morphological change of T cell which contacts DC and the relationship between morphological change and T-cell activation are not very clear. Thus, we studied the morphological change of CD4(+) T cell during contact with DC. Using live-cell imaging, we discovered diversity in the T-cell morphological changes during contact with DCs. The elongation-flattening of CD4(+) T cells correlated with a low-level Ca(2+) response and a loss of T-cell receptor (TCR) signalling molecules in the IS, including zeta-chain associated protein kinase 70 (ZAP-70), phospholipase C-γ (PLC-γ) and protein kinase C-θ (PKC-θ), whereas rounding-flattening correlated with sufficient CD4(+) T-cell activation. Different morphological changes were correlated with the different amount of accumulated filamentous actin (F-actin) in the IS. Disruption of F-actin by cytochalasin D impaired the morphological change and the localisation of calcium microdomains in the IS and decreased the calcium response in CD4(+) T cells. Our study discovered the diversity in morphological change of T cells during contacted with DCs. During this process, the different morphological changes of T cells modulate T-cell activation by the different amount of F-actin accumulation in the IS, which controls the distribution of calcium microdomains to affect T-cell activation.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

AV50117
Anti-ORAI1 (AB1) antibody produced in rabbit, affinity isolated antibody
O8264
Anti-ORAI1 antibody produced in rabbit, ~1.0 mg/mL, affinity isolated antibody, buffered aqueous solution
HPA016583
Anti-ORAI1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB3500412
Anti-ORAI1 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB4503106
Anti-ZAP-70 antibody produced in rabbit, affinity isolated antibody
SAB4503107
Anti-ZAP-70 antibody produced in rabbit, affinity isolated antibody
SAB4503108
Anti-ZAP-70 antibody produced in rabbit, affinity isolated antibody
SAB4503109
Anti-ZAP-70, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB4300437
Anti-ZAP70 (Ab-319) antibody produced in rabbit, affinity isolated antibody
SAB4300438
Anti-ZAP70 (Ab-493) antibody produced in rabbit, affinity isolated antibody
SAB2502042
Anti-ZAP70 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
HPA003134
Anti-ZAP70 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2107611
Anti-ZAP70 antibody produced in rabbit, affinity isolated antibody
SAB4200273
Monoclonal Anti-Orai1 antibody produced in mouse, ~1.0 mg/mL, clone ORAI1-89, purified immunoglobulin
SAB3500126
Monoclonal Anti-ORAI1 antibody produced in mouse, clone 3F6H5, purified immunoglobulin, buffered aqueous solution
SAB3500127
Monoclonal Anti-ORAI1 antibody produced in mouse, clone 6D11A11, purified immunoglobulin, buffered aqueous solution
Z0627
Monoclonal Anti-ZAP-70 antibody produced in mouse, ~1.5 mg/mL, clone 1E7.2, purified immunoglobulin, buffered aqueous solution
SAB4700528 Monoclonal Anti-ZAP70 , (C-terminal) antibody produced in mouse, clone ZAP-03, purified immunoglobulin, buffered aqueous solution
WH0007535M1
Monoclonal Anti-ZAP70 antibody produced in mouse, clone 2F6, purified immunoglobulin, buffered aqueous solution